BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18929897)

  • 1. Effect of aciclovir on HIV-1 acquisition in HSV-2-positive patients.
    Hudson CP
    Lancet; 2008 Oct; 372(9646):1298; author reply 1298-9. PubMed ID: 18929897
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating HIV infection with drugs for HSV-2 infection?
    Buvé A; Lynen L
    Lancet; 2010 Mar; 375(9717):782-4. PubMed ID: 20153889
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
    Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
    Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of HIV infection with drugs for HSV-2 infection.
    Huttner A; Calmy A
    Lancet; 2010 Jul; 376(9735):88; author reply 88. PubMed ID: 20621229
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
    Celum C; Wald A; Hughes J; Sanchez J; Reid S; Delany-Moretlwe S; Cowan F; Casapia M; Ortiz A; Fuchs J; Buchbinder S; Koblin B; Zwerski S; Rose S; Wang J; Corey L;
    Lancet; 2008 Jun; 371(9630):2109-19. PubMed ID: 18572080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV/AIDS. Prevention cocktails: combining tools to Stop HIV's spread.
    Cohen J
    Science; 2005 Aug; 309(5737):1002-5. PubMed ID: 16099959
    [No Abstract]   [Full Text] [Related]  

  • 7. HSV-2 suppression and the incidence of HIV.
    Lisco A; Vanpouille C
    N Engl J Med; 2008 Jul; 359(5):535; author reply 535. PubMed ID: 18669436
    [No Abstract]   [Full Text] [Related]  

  • 8. Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”.
    Cohen MS; Eron JJ
    Sex Transm Dis; 2011 May; 38(5):410-2. PubMed ID: 22256341
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticipated "slam dunk" treatment fails.
    AIDS Read; 2008 Apr; 18(4):208. PubMed ID: 18476288
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
    Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
    AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial shows HSV-2 suppression can reduce HIV shedding.
    IAVI Rep; 2006; 10(1):20. PubMed ID: 16628770
    [No Abstract]   [Full Text] [Related]  

  • 12. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Ruark AH; Shelton JD; Halperin DT
    N Engl J Med; 2010 May; 362(18):1741; author reply 1741-2. PubMed ID: 20449879
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Gray R; Wilson D
    N Engl J Med; 2010 May; 362(18):1740; author reply 1741-2. PubMed ID: 20445189
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence in HIV type 1 prevention trials.
    Baeten JM
    J Infect Dis; 2010 May; 201(9):1279-81. PubMed ID: 20235837
    [No Abstract]   [Full Text] [Related]  

  • 15. Reassessing the hypothesis on STI control for HIV prevention.
    Gray RH; Wawer MJ
    Lancet; 2008 Jun; 371(9630):2064-5. PubMed ID: 18572064
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in the management of herpes simplex virus infection in HIV-infected persons.
    Bartlett JG
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S237-9. PubMed ID: 15494894
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
    Fuchs J; Celum C; Wang J; Hughes J; Sanchez J; Cowan F; Reid S; Delany-Moretlwe S; Corey L; Wald A;
    J Infect Dis; 2010 Apr; 201(8):1164-8. PubMed ID: 20214474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Celum C; Wald A; Lingappa JR; Magaret AS; Wang RS; Mugo N; Mujugira A; Baeten JM; Mullins JI; Hughes JP; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Stevens W; Campbell MS; Thomas KK; Coombs RW; Morrow R; Whittington WL; McElrath MJ; Barnes L; Ridzon R; Corey L;
    N Engl J Med; 2010 Feb; 362(5):427-39. PubMed ID: 20089951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.
    Leichliter JS; Lewis DA; Sternberg M; Habel MA; Paz-Bailey G
    Sex Transm Dis; 2011 Sep; 38(9):865-70. PubMed ID: 21844743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS research. Promising prevention interventions perform poorly in trials.
    Cohen J
    Science; 2007 Jul; 317(5837):440. PubMed ID: 17656693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.